TP53 and neoplasm: This effect of tumor cells appears to be mediated by MDMX phosphorylation-dependent p53 downregulation in the host because blocking this MDMX phosphorylation prevented p53 decline and effectively mitigated the immunosuppressive TME, resulting in tumor growth delay.